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Changing patterns in the histopathology of idiopathic nephrotic The International Study of Kidney Disease in Children
syndrome in children. (ISKDC) reported in the 1970s that minimal change ne-
Background. It is widely accepted that minimal change ne- phrotic syndrome (MCNS) was the most common histo-
phrotic syndrome (MCNS) is the most common cause of ne-
logical lesion in renal biopsies from children with idio-phrosis in children. Recent studies have demonstrated an in-
pathic nephrotic syndrome [1, 2]. This observation wascreasing incidence of focal segmental glomerulosclerosis (FSGS)
confirmed by single centers that reported MCNS in al-in adults.
Methods. To determine possible changes in the etiology of most 90% of cases [3]. The same studies showed that
childhood nephrosis, the clinical charts of 152 pediatric patients focal segmental glomerulosclerosis (FSGS) was a rare
diagnosed with idiopathic nephrotic syndrome between 1978 cause of nephrosis in children, observed in only 5 to 7%and 1997 were reviewed. Histopathological diagnosis was avail-
of the biopsies [1–3]. More recent studies in adults haveable in 105 patients.
reported an increasing incidence of FSGS during the lastResults. MCNS was present in 35% of all biopsies, whereas
FSGS was observed in 31%. Even if we assume that all patients 20 years, accompanied by a significant decline in the
without a histological diagnosis had MCNS (presumptive incidence of MCNS [4]. D’Agati has suggested that FSGS
MCNS), the total incidence of MCNS (biopsy proven 1 pre- constitutes the most common glomerulopathy observed
sumptive) in our population was only 55%. We observed a
among biopsies performed in adult native kidneys [5].dramatic increase in the incidence of FSGS during recent years.
Unfortunately, in the pediatric population, the only stud-Before 1990, FSGS was diagnosed in 23% of all renal biopsies
ies performed during the last 20 years have focused onbut increased to 47% afterward (P 5 0.02). This pattern was
observed in all ethnic groups. In African Americans, there was selected patient populations that were either steroid de-
a trend for an increase in the incidence of FSGS from 38% pendent or frequent relapsers. In 1981, Siegel et al re-
before 1990 to 69% after 1990. A similar trend was observed ported that FSGS was present in 29% of renal biopsiesin Caucasians (from 20 to 45%) and Hispanics (from 8 to 33%).
performed in children with steroid-dependent nephroticHispanics had the highest incidence of MCNS (biopsy proven 1
syndrome [6]. Trachtman and colleagues later observedpresumptive: 73%), followed by Caucasians (53%) and African
Americans (37%). The mean age for presentation of nephrotic that MCNS was present in 25% of the biopsies per-
syndrome in African Americans (8.0 6 0.9 years) was higher formed in pediatric patients with frequently relapsing,
than in Caucasians (4.1 6 0.05) and Hispanics (3.3 6 0.5). steroid-sensitive nephrotic syndrome [7].
Conclusions. Our study showed that the incidence of FSGS It has been our impression that the incidence of FSGSin children with idiopathic nephrotic syndrome has increased
has increased in our practice during recent years. Inrecently. Furthermore, in African American children, FSGS is
addition, in agreement with observations from other cen-the most common cause of nephrotic syndrome. These findings
may have significant implications in the management of child- ters, we have observed a marked predominance of FSGS
hood nephrotic syndrome. among African American patients [8–10]. Recently, in a
primarily Black population of adolescents with nephrotic
syndrome, Baqi et al demonstrated that FSGS was the
1 See Editorial, p. 2072. most common histological finding with an incidence of
55.2% [11]. Conversely, in a primarily White and AsianKey words: minimal change nephrotic syndrome, focal segmental glo-
merulonephritis, renal biopsy, childhood nephrosis. pediatric population in United Kingdom, Webb et al
noted that MCNS was the most common histological
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results of these two studies could be limited by the racial increase in mesangial matrix and/or segmental cell prolif-
composition of their populations. eration was observed. FSGS was characterized by the
This study reports our experience with pediatric idio- presence of at least one glomerulus showing a segmental
pathic nephrotic syndrome during the last 20 years in a area of sclerosis with or without accompanying tubular
racially mixed population of a major urban city in the atrophy and interstitial fibrosis. Thirty-two out of 33
United States. The demographic data and histopatholog- patients diagnosed with FSGS had three or more glomer-
ical findings were reviewed. uli with segmental sclerotic lesions. Mesangial prolifera-
tive glomerulonephritis was defined by the presence of
increased mesangial matrix and moderate to prominentMETHODS
mesangial cell proliferation (more than 4 cells per mesan-
Patients gial area), in the absence of segmentally sclerosed glo-
Between 1978 and 1997, 152 children with idiopathic meruli. Because of the controversies regarding the sig-
nephrotic syndrome were evaluated at University of nificance of IgM deposits in the mesangium, IgM
Texas-Houston Health Science Center. Except for two nephropathy was not considered as a separate entity
patients who had received therapy with prednisone for [14–16]. Therefore, patients with or without IgM deposits
a week, the remaining patients were referred for nephro- by immunofluorescence microscopy were grouped to-
logic evaluation of edema or new diagnosis of nephrotic gether in this category. Patients who had mesangial
syndrome, prior to commencing therapy. None of the changes accompanied by IgA deposits were included in
patients had been biopsied before evaluation by the ne- a separate group (IgA nephropathy). Because it is our
phrology service. Patients with systemic illnesses such as practice to treat most patients with corticosteroids prior
systemic lupus erythematosus, Henoch-Scho¨nlein pur- to kidney biopsy, a group of patients who readily re-
pura, sickle cell anemia, malignancies, metabolic disor- sponded to prednisone and had no or only occasional
ders, or hepatitis or those who were receiving drugs asso- relapses (31% of our population) was never biopsied.
ciated with the onset of nephrotic syndrome were We defined this group of patients as presumptive MCNS,
excluded. Indications for biopsy included steroid resis-
although we recognize that it might represent a more
tance or dependence, frequent relapses, an age older
heterogenous group of diseases. In patients who had hadthan eight years, or significant elevation in serum creati-
more than one biopsy, the histopathological diagnosisnine at presentation. All patients were treated initially
was assigned according to the results of the most recentwith corticosteroids (prednisone) at a dose of 2 mg/kg/
biopsy.day (maximum of 80 mg/day) for four to eight weeks.
None of the patients were treated with cytotoxics or Statistical analysis
cyclosporine prior to kidney biopsy.
Data from groups of patients are reported as mean 6
se or as percentages (frequency of observation in a par-Definitions
ticular group). The statistical analysis was performed byNephrotic syndrome was defined as the association of
chi-square test or analysis of variance for comparisonsheavy proteinuria with hypoalbuminemia and hypercho-
between multiple groups. Statistical significance was de-lesterolemia. The response to therapy was classified ac-
fined as a P # 0.05.cording to the definitions from ISKDC: (a) steroid sensi-
tive—complete resolution of proteinuria within eight
weeks of prednisone therapy; (b) steroid resistance— RESULTS
failure to respond to eight consecutive weeks of treat-
Our population was represented by three major ethnicment with prednisone at 2 mg/kg/day; (c) steroid depen-
groups: Caucasians (N 5 74, 49%), African Americansdence—recurrence of nephrosis when the dose of
(N 5 30, 20%), and Hispanics (N 5 37, 24%). This wascorticosteroids is reduced or within two months after the
similar to the general composition of Houston’s popula-discontinuation of therapy; (d) frequent relapses—two
tion: Caucasians, 40.6%; African Americans, 27.5%; andor more episodes of nephrosis within six months of the
Hispanics, 27.6% [17]. The mean age of our populationinitial response or four or more within any 12-month
was 5.3 6 4.3 (range of 1 to 20 years old), with a slightperiod (not related to changes in prednisone dose) [13].
male predominance (57%). Hypertension, defined as
Pathology blood pressure higher than the 95th percentile for age
according to data from the Task Force Report on HighRenal tissue was examined by light, immunofluores-
Blood Pressure in Children and Adolescents, was ob-cence, and electron microscopy and was interpreted by
served in 21% [18]. Microscopic hematuria, defined asour renal pathologists. Minimal change disease was char-
more than five red blood cells per high-power field inacterized by the absence of any conspicuous abnormality
on light microscopy. In some specimens, a very slight the initial urinalysis, was observed in 32% of the patients.
Bonilla-Felix et al: Nephrotic syndrome in children 1887
Table 3. Distribution of histopathology by ethnicityTable 1. Distribution of histopathological lesions
All patients N (%) Biopsy specimens N (%) Caucasian African American Hispanic
Histological lesion (N 5 152) (N 5 105)
Histological lesion N (%)
MCNS-Bx 37 (24%) 37 (35%)
MCNS-Bx 16 (22%) 7 (23%) 11 (30%)MCNS-Pres 47 (31%)
MCNS-Pres 23 (31%) 4 (13%) 16 (43%)FSGS 33 (22%) 33 (31%)
FSGS 13 (18%) 14 (47%) 4 (11%)Mesangial 26 (17%) 26 (25%)
Mesangial 16 (22%) 4 (13%) 4 (11%)MPGN 5 (3%) 5 (5%)
MPGN 4 (5%) 0 (0%) 1 (3%)IGA 2 (1%) 2 (2%)
IGA 1 (1%) 1 (3%) 0 (0%)Others 2 (1%) 2 (2%)
Others 1 (1%) 0 (0%) 1 (3%)
Abbreviations are: MCNS-Bx, biopsy-proven minimal change nephrotic syn-
Abbreviations are: MCNS-Bx, biopsy-proven minimal change nephrotic syn-drome; MCNS-Pres, presumptive minimal change nephrotic syndrome; Mesan-
drome; MCNS-Pres, presumptive minimal change nephrotic syndrome; mesan-gial, mesangial proliferative glomerulonephritis; MPGN, membranoproliferative
gial, mesangial proliferative glomerulonephritis; MPGN, membranoproliferativeglomerulonephritis; IGA, IgA nephropathy.
glomerulonephritis; IGA, IgA nephropathy.
Table 2. Changes in histopathology after 1990 it did not reach statistical significance Table 3). If the
group of patients who were not biopsied (presumptiveHistological Incidence Odds Confidence
lesion Year N (%) ratio interval P value MCNS) were included in the analysis, the incidence of
FSGS After 1990 17 (47%) 2.94 0.0533, 0.4272 0.02 MCNS (presumptive 1 biopsy proven) after 1990 (57%)
Before 1990 16 (23%) did not differ from prior to 1990 (54%).
MCNS-Bx After 1990 9 (25%) 0.48 20.0367, 0.3483 0.17
Table 3 demonstrates the distribution of diagnosisBefore 1990 28 (41%)
Mesangial After 1990 7 (19%) 0.63 20.0930, 0.2549 0.50 among the three major ethnic groups. FSGS was the
Before 1990 19 (28%) most common diagnosis in African American children
Abbreviations are: MCNS-Bx, biopsy-proven minimal change nephrotic syn- with nephrotic syndrome (47%). This was significantly
drome; Mesangial, mesangial proliferative glomerulonephritis.
higher than in Caucasian (18%, odds ratio 5 4.11, P 5
0.003) and Hispanic children (11%, odds ratio 5 7.22,
P 5 0.003). When we limit the analysis to biopsy speci-
mens (excluding patients with presumptive MCNS), the
Table 1 shows the distribution of causes of nephrotic overall incidence of FSGS in African Americans (54%)
syndrome in our population. Minimal change was pres- is still significantly higher than in Caucasians (25%, odds
ent in only 35% of all biopsies performed. Even if we ratio 5 3.41, P 5 0.03) and Hispanics (19%, odds ratio 5
assume that all children that were not biopsied had 4.96, P 5 0.03). Conversely, the highest incidence of
MCNS (presumptive MCNS), the total incidence of MCNS (presumptive 1 biopsy proven) was observed
MCNS (presumptive 1 biopsy proven) was 55%, which among Hispanic children (73%), followed by Caucasian
differs from numbers previously reported by the Interna- children (53%), with the lowest being in African Ameri-
tional Study of Kidney Disease in Children (ISKDC) cans children (36%), but these differences were not statis-
tically significant.[2]. By contrast, FSGS was observed in 31% of the biop-
To determine if the increasing incidence of FSGS wassies and accounted for 22% of all cases of nephrotic
the result of changes in the racial composition of oursyndrome. This is higher than predicted for a pediatric
population, we analyzed the ethnical distribution of ourgroup. Mesangial proliferative glomerulonephritis was
patients before and after 1990. The number of Caucasianthe third most common diagnosis, and was present in
patients evaluated for nephrotic syndrome in our center25% of the biopsies.
declined from 58% prior to 1990 and 35% after 1990.To determine whether the high incidence of FSGS
Concurrently, the African American population increasedwas the result of an increasing trend during recent years,
from 17 to 24%, and the number of Hispanic childrenwe subdivided our group into patients who developed
increased from 17 to 35%. Although not statistically sig-
nephrotic syndrome before 1990 and patients who pre- nificant, there was a trend for a higher incidence of FSGS
sented on or after 1990. FSGS was the most common in all ethnic groups after 1990 (African Americans, 38 to
histological lesion observed among the biopsies per- 69%; Caucasians, 20 to 45%; Hispanics, 8 to 33%).
formed in patients presenting after 1990 (47%; Table Finally, the potential differences in diagnoses with age
2). This was significantly higher than in biopsies from of the patients were examined. We observed that the mean
patients who presented prior to 1990 (23%, P 5 0.02). age of our population did not change between the two
There was a tendency for a lower incidence of biopsy- time periods studied (before 1990, 5.1 6 0.4; after 1990,
proven MCNS and mesangial proliferative glomerulone- 5.7 6 0.6 years old, P 5 0.34). Furthermore, the median
age for both time periods was the same (four years old),phritis (with and without IgM deposits) after 1990, but
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Table 4. Distribution of histopathology by age a higher incidence of FSGS is expected [6, 7]. Studies in
adults have reported that the incidence of FSGS hasHistological Age Incidence Odds Confidence
lesion years N (%) ratio interval P value increased during recent years [4, 5].
MCNS .8 13 (35%) 0.29 0.1179, 0.4937 0.002 Our results demonstrate a high incidence of FSGS in
(Bx 1 Pres) ,8 75 (65%) our pediatric population with nephrotic syndrome. FSGS
FSGS .8 18 (49%) 6.25 0.2033, 0.5088 0.00001
was identified as the cause of nephrotic syndrome in 22%,8 15 (13%)
Mesangial .8 2 (5%) 0.22 0.05 of all pediatric patients evaluated in our center after 1990.
,8 24 (21%) This represents 31% of the biopsy specimens. This is the
Abbreviations are: Bx 1 Pres, biopsy-proven plus presumptive minimal highest incidence of FSGS ever reported in a pediatric
change nephrotic syndrome; Mesangial, mesangial proliferative glomerulone-
population. The odds of a diagnosis of FSGS in a biopsyphritis.
specimen of a child with nephrotic syndrome in the cur-
rent decade is almost three times higher than prior to
1990. This agrees with the pattern described in adult
suggesting that the increased incidence in FSGS was not series [4, 5]. We believe that our observations represent
result of an age increase in our population. The distribu- a true increase in the incidence of FSGS. Although our
tion of diagnoses was subdivided into two age groups (less practice is established in a university-affiliated tertiary
than eight years vs. more than eight years old). This age care center, it does not seem that our results were biased
was chosen because it has been our limit to treat patients by selection of patients with more severe disease. None
empirically with corticosteroids without histological diag- of our patients was referred to us for evaluation of ste-
nosis. The causes of nephrotic syndrome in these groups roid-resistant or steroid-dependent nephrotic syndrome.
were significantly different. As shown in Table 4, MCNS Furthermore, except for two patients who had been
(presumptive 1 biopsy proven) was more common in the treated with prednisone for a week, the rest of our pa-
younger age group (less than eight years, 65%; more than tients were referred for evaluation of edema or new
eight years, 35%, odds ratio 5 3.5, P 5 0.002). Similarly, onset nephrotic syndrome before treatment had been
the incidence of mesangial proliferative glomerulonephri- commenced. Our findings are in accordance with prelimi-
tis in children younger than eight years (21%) was signifi- nary data from Sorof et al, who reported FSGS as the
cantly higher than in the older group (5%, odds ratio 5 cause of proteinuria in 28% of pediatric patients in Hous-
4.62, P 5 0.05). By contrast, FSGS was significantly more ton (abstract; Sorof et al, J Am Soc Nephrol 8:98A, 1997).
common in the older patients (49 vs. 13%, odds ratio 5 Ethnicity seems to play a critical role in the epidemiol-
6.3, P 5 0.00001). Moreover, although the incidence of ogy of nephrotic syndrome. As previously reported by
FSGS in patients older than eight years almost doubled others [8–11], we also observed a strong predominance
of FSGS among African Americans (Table 4). FSGS wasafter 1990 (63 vs. 33%, before 1990), it did not change in
the most common histological lesion observed in thisthe younger patients (14% before 1990 vs. 11% after
ethnic group. African American children with nephrotic1990). In addition, a significant difference in the ages at
syndrome have a seven times greater risk of having beenpresentation was observed between the different ethnic
diagnosed with FSGS than Hispanics. Indeed, we foundgroups. The mean age for presentation of nephrotic syn-
that Hispanics had the lowest risk for FSGS and thedrome in African American children (8.0 6 0.9 years old)
highest incidence of MCNS among the three racialwas significantly higher than in Caucasians (4.1 6 0.5, P ,
groups analyzed. This finding differs from observations0.01) and Hispanics (3.3 6 0.5, P , 0.001).
by Ingulli and Tejani, who reported that the incidence
of FSGS in Hispanic children with nephrotic syndrome
DISCUSSION in New York was higher than in Caucasians and not
It has been widely accepted that MCNS is by far the different from Blacks [8]. Unfortunately, in this study,
most common cause of nephrotic syndrome in children. the data of Hispanic children were not separated from
The ISKDC reported almost 30 years ago that MCNS the African American group. This fact did not allow us
was present in 77% of all renal biopsies performed in to compare the differences between these two Hispanic
children with idiopathic nephrotic syndrome [1, 2]. Oth- populations. Nonetheless, it should be noted that our
ers reported MCNS in up to 90% [3]. For years, these results agree with preliminary observations from our col-
observations have guided the management of pediatric leagues in Houston, who reported no difference in the
patients with nephrotic syndrome. More recent studies incidence of FSGS between Hispanic and Caucasian chil-
from Siegel et al and Trachtman et al have shown a dren with proteinuria (abstract; Sorof et al, J Am Soc
higher incidence of FSGS in pediatric patients with ste- Nephrol 8:98A, 1997). The contrasting differences be-
roid-sensitive nephrotic syndrome. However, both of tween Ingulli’s report and ours could be related to ge-
these studies focused on high-risk populations that were netic factors. The Hispanic population in New York was
largely formed by Puerto Ricans and other Caribbeaneither steroid dependent or frequent relapsers, in which
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immigrants, whereas in Houston, Mexicans and other nosis [20]. Although initially considered a resistant lesion,
immigrants from Central America comprised the major- recent data suggest that more aggressive therapies can
ity of the Hispanic group. induce a response in more than 50% of patients [21–24].
A potential explanation for this recent surge in FSGS Furthermore, patients who achieve remission have a sig-
could be a change in the ethnic composition of our popu- nificantly improved clinical course [22]. We propose that
lation. However, although there was a decline in the a biopsy, either at the onset of nephrotic syndrome in
Caucasian population and a slight increase in the number patients at risk (older than eight years, African Ameri-
of African American children in our group during the cans) or early during the clinical course if problems with
study period, the major demographic change observed response to therapy are identified, will be beneficial in
was an almost doubling in the number of Hispanic pa- the management of these patients.
tients after 1990. This correlates with the demographic
changes occurring in Houston. Figures from the U.S. ACKNOWLEDGMENTS
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